CPSH · Cps Technologies Corp/De/ - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $32.60M | $21.12M | $27.55M | $26.59M | $22.45M | $20.87M |
| Cost of Revenue | $27.31M | $21.24M | $20.73M | $19.29M | $17.66M | $16.70M |
| Gross Profit | $5.29M | ($118.6K) | $6.83M | $7.30M | $4.79M | $4.17M |
| R&D | $867.7K | - | - | - | - | - |
| SG&A | $4.85M | $4.26M | $5.13M | $5.07M | $4.28M | $3.26M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $601.2K | $547.2K | $489.1K | $445.7K | $469.3K | $530.4K |
| Operating Income | $444.0K | ($4.38M) | $1.70M | $2.23M | $513.0K | $914.2K |
| Interest Expense | - | - | $5.1K | $10.9K | $10.9K | - |
| Income Tax | $262.3K | ($958.5K) | $582.1K | $756.3K | ($2.71M) | ($8.5K) |
| Net Income | $420.4K | ($3.14M) | $1.37M | $2.13M | $3.22M | $908.1K |
| EPS - Basic | $0.03 | ($0.22) | $0.09 | $0.15 | $0.23 | $0.07 |
| EPS - Diluted | $0.03 | ($0.22) | $0.09 | $0.15 | $0.22 | $0.07 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.47M | $3.28M | $8.81M | $8.27M | $5.05M | $195.2K |
| Accounts Receivable | - | - | $4.39M | $3.78M | $4.87M | - |
| Inventory | $5.60M | $4.33M | $4.58M | $4.88M | $3.91M | $3.71M |
| Accounts Payable | - | $3.05M | $2.54M | $1.84M | $2.10M | $909.3K |
| Current Assets | $24.75M | $14.16M | $18.14M | $17.82M | $14.06M | $6.89M |
| Total Assets | $29.51M | $18.88M | $21.60M | $21.68M | $18.80M | - |
| Current Liabilities | $4.67M | $4.31M | $4.07M | $5.38M | $5.10M | $1.81M |
| Long-term Debt | - | $8.1K | $54.9K | $98.7K | $154.6K | - |
| Total Liabilities | $4.88M | $4.36M | $4.28M | $5.97M | $5.63M | $1.96M |
| Stockholders' Equity | $24.64M | $14.51M | $17.32M | $15.71M | $13.17M | $6.36M |
| Retained Earnings | ($25.47M) | ($25.89M) | ($22.75M) | ($24.13M) | ($26.26M) | ($29.47M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $243.6K | ($3.48M) | $1.27M | $3.55M | $2.01M | $1.67M |
| Investing Cash Flow | ($8.50M) | ($2.01M) | ($718.3K) | ($436.4K) | ($512.3K) | ($312.0K) |
| Financing Cash Flow | $9.44M | ($46.8K) | ($2.3K) | $101.4K | $3.36M | ($1.29M) |
| CapEx | $730.7K | $994.3K | $718.3K | $439.8K | $514.3K | - |
| Free Cash Flow | ($487.0K) | ($4.47M) | $549.2K | $3.11M | $1.49M | - |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 16.2% | -0.6% | 24.8% | 27.5% | 21.3% | 20.0% |
| Operating margin | 1.4% | -20.7% | 6.2% | 8.4% | 2.3% | 4.4% |
| EBITDA margin | 3.2% | -18.1% | 7.9% | 10.1% | 4.4% | 6.9% |
| Net margin | 1.3% | -14.8% | 5.0% | 8.0% | 14.3% | 4.4% |
| Free cash flow margin | -1.5% | -21.2% | 2.0% | 11.7% | 6.6% | - |
| FCF / Net income | -1.16 | 1.43 | 0.40 | 1.46 | 0.46 | - |
| R&D / Revenue | 2.7% | - | - | - | - | - |
| SG&A / Revenue | 14.9% | 20.2% | 18.6% | 19.1% | 19.1% | 15.6% |
| Effective tax rate | 38.4% | - | 29.8% | 26.2% | -531.9% | -1.0% |
| Return on assets | 1.4% | -16.6% | 6.3% | 9.8% | 17.1% | - |
| Return on equity | 1.7% | -21.6% | 7.9% | 13.6% | 24.4% | 14.3% |
| Return on invested capital | - | -23.8% | 6.9% | 10.4% | 3.9% | - |
| Liquidity | ||||||
| Current ratio | 5.30 | 3.29 | 4.46 | 3.31 | 2.75 | 3.81 |
| Quick ratio | 4.10 | 2.28 | 3.33 | 2.41 | 1.99 | 1.76 |
| Cash ratio | 0.96 | 0.76 | 2.17 | 1.54 | 0.99 | 0.11 |
| Leverage | ||||||
| Debt / Equity | - | 0.00 | 0.00 | 0.01 | 0.01 | - |
| Debt / Assets | - | 0.00 | 0.00 | 0.00 | 0.01 | - |
| Debt / EBITDA | - | - | 0.03 | 0.04 | 0.16 | - |
| Interest coverage | - | - | 333.5x | 205.3x | 47.1x | - |
| Equity multiplier | 1.20 | 1.30 | 1.25 | 1.38 | 1.43 | - |
| Liabilities / Assets | 0.17 | 0.23 | 0.20 | 0.28 | 0.30 | - |
| Efficiency | ||||||
| Asset turnover | 1.10 | 1.12 | 1.28 | 1.23 | 1.19 | - |
| Inventory turnover | 4.88 | 4.90 | 4.52 | 3.96 | 4.51 | 4.50 |
| Days sales outstanding | - | - | 58d | 52d | 79d | - |
| Days inventory outstanding | 75d | 74d | 81d | 92d | 81d | 81d |
| Days payable outstanding | - | 52d | 45d | 35d | 43d | 20d |
| Cash conversion cycle | - | - | 94d | 109d | 117d | - |
| Valuation | ||||||
| P / E | 103.0x | - | 26.1x | 17.9x | 17.2x | 32.7x |
| P / B | 1.9x | 1.6x | 2.0x | 2.5x | 4.2x | 4.8x |
| P / S | 1.5x | 1.1x | 1.2x | 1.5x | 2.5x | 1.5x |
| EV / EBITDA | 41.2x | - | 11.7x | 11.7x | 51.3x | 21.0x |
| Growth | ||||||
| Revenue growth (YoY) | 54.3% | -23.3% | 3.6% | 18.4% | 7.6% | -2.8% |
| Revenue CAGR (3y) | 7.0% | -2.0% | 9.7% | 7.4% | 15.5% | 12.7% |
| Revenue CAGR (5y) | 9.3% | -0.3% | 13.6% | 12.8% | 7.9% | -0.8% |
| Gross profit growth (YoY) | - | - | -6.5% | 52.4% | 14.9% | 64.1% |
| Operating income growth (YoY) | - | - | -23.9% | 335.6% | -43.9% | - |
| Net income growth (YoY) | - | - | -35.7% | -33.7% | 254.1% | - |
| EPS growth (YoY) | - | - | -40.0% | -31.8% | 214.3% | - |
| EPS CAGR (3y) | -41.5% | - | 8.7% | - | - | - |
| EPS CAGR (5y) | -15.6% | - | - | - | - | 18.5% |
| FCF growth (YoY) | 89.1% | - | -82.4% | 108.5% | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | 69.8% | -16.2% | 10.3% | 19.3% | 107.1% | 18.5% |
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
3.03
Safe
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
5/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✓ROA improved YoY
- ✗Cash flow > net income
- -Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✓Gross margin improved
- ✗Asset turnover improved